Find A Quick Way To Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so might be grounds for compensation. Our lawyers are operating tough to have those hurt by the drug the compensation they may be entitled to. While bleeding is a frequent complication related with anticoagulants, it has been alleged that Xarelto is much more harmful than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, inside the occasion of an emergency, sufferers may possibly be at risk for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging. In the event you or perhaps a loved 1 suffered a serious bleeding occasion after taking Xarelto, you may have legal recourse. For far more details, contact us today to have your case reviewed, free of charge of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and,  http://xareltolegalinformation.bitbucket.org/categories/Michigan/Reversal-Agent-For-Xarelto-Kingsford-MI-49802.html in cases of death, funeral expenses. In addition, they're looking for punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly. Why Are Lawsuits Getting Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a secure anticoagulant option. Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event. Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting. Visit this page for more data on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.